semaglutide covered by insurance for weight loss As demand weight-loss drugs rises, states grapple with Medicaid coverage • SC Daily Gazette Medicare will now cover weight

Sends stronger Im full signals to the brain

Approval of the higher dose was based on the findings of the STEP UP clinical trial, results of which were published in November 2025

Arundel stressed that the risk remains rare, with estimates suggesting it may affect up to one in every 10,000 people taking these medicines

Clinical Rheumatology

Wissam Ghusn of the Precision Medicine for Obesity Program at the Mayo Clinic in Minnesota based their findings on a study of 93 people who were either overweight or had obesity along with a body-mass index (BMI) of 27 or higher and no prior history of cardiovascular disease

Researchers analyzed data from over 100,000 individuals with diabetes and reported that users of GLP-1 receptor agonists like Ozempic may face an increased risk of developing NAION compared to those on other diabetes treatments